SGC-CLK-1, with the CAS number 748142-15-6, is a chemical compound that functions primarily as a selective inhibitor of CLK kinases, which are involved in various cellular processes, including cell cycle regulation and RNA splicing. This compound is characterized by its ability to modulate the activity of CLK1 and CLK2, making it a valuable tool in research related to cancer and other diseases where these kinases play a critical role. SGC-CLK-1 is typically studied for its potential therapeutic applications, particularly in the context of targeting specific signaling pathways. Its chemical structure includes functional groups that contribute to its binding affinity and selectivity for CLK kinases. Additionally, SGC-CLK-1 has been utilized in various biochemical assays to elucidate the role of CLK kinases in cellular functions and to explore the broader implications of kinase inhibition in therapeutic contexts. As with many research compounds, safety and handling precautions should be observed when working with SGC-CLK-1 in laboratory settings.

SGC-CLK-1

748142-15-6: SGC-CLK-1, with the CAS number 748142-15-6, is a chemical compound that functions primarily as a selective inhibitor of CLK kinases, which are involved in various cellular processes, including cell cycle regulation and RNA splicing. This compound is characterized by its ability to modulate the activity of CLK1 and CLK2, making it a valuable tool in research related to cancer and other diseases where these kinases play a critical role. SGC-CLK-1 is typically studied for its potential therapeutic applications, particularly in the context of targeting specific signaling pathways. Its chemical structure includes functional groups that contribute to its binding affinity and selectivity for CLK kinases. Additionally, SGC-CLK-1 has been utilized in various biochemical assays to elucidate the role of CLK kinases in cellular functions and to explore the broader implications of kinase inhibition in therapeutic contexts. As with many research compounds, safety and handling precautions should be observed when working with SGC-CLK-1 in laboratory settings.

SGC-CLK-1 is a potent and selective inhibitor of Cdc2-like kinases CLK1, CLK2, and CLK4. It effectively inhibits the growth of melanoma and glioblastoma cells.

CAS 748142-15-6

SGC-CLK-1

SGC-CLK-1

Ref: TM-T201181